Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Enzyme immunoassay is used to probe serum and plasma levels of tumor-necrosis factor-alpha (TNFα) in human heart transplant patients during the first few months post-transplantation. Detectability of TNFα was increased by heat-pretreatment of serum (56°C for 30 minutes), in order to inactivate inhibitors of the immunoassay present in the sera. In EDTA-treated plasma samples such treatment was not necessary, thus suggesting the possible involvement of complement in such inhibition. Compared with samples from control (healthy) volunteers, transplant patients frequently displayed elevated levels of TNFα, especially in the first few weeks post-transplantation. However, increased cytokine levels did not correlate with histologically (biopsy)-determined rejection episodes. We were unable to detect interleukin-6 (IL-6) in plasma samples of heart transplant patients.

Type

Journal article

Journal

Clinical Transplantation

Publication Date

01/01/1993

Volume

7

Pages

459 - 466